Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension.

about

Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension.

Item

http://www.wikidata.org/entity/Q48249984

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical impact of angiotensin ...... s with resistant hypertension.

@en

Clinical impact of angiotensin ...... s with resistant hypertension.

@nl

type

Item

label

Clinical impact of angiotensin ...... s with resistant hypertension.

@en

Clinical impact of angiotensin ...... s with resistant hypertension.

@nl

prefLabel

Clinical impact of angiotensin ...... s with resistant hypertension.

@en

Clinical impact of angiotensin ...... s with resistant hypertension.

@nl

P1476

Clinical impact of angiotensin ...... ts with resistant hypertension

@en

P2093

Angela Alibrandi

http://www.w3.org/2001/XMLSchema#string

Antonino Saitta

http://www.w3.org/2001/XMLSchema#string

Federica Mamone

http://www.w3.org/2001/XMLSchema#string

Francesca Felice

http://www.w3.org/2001/XMLSchema#string

Giovanni Trapani

http://www.w3.org/2001/XMLSchema#string

Marco Vatrano

http://www.w3.org/2001/XMLSchema#string

Michele Scuruchi

http://www.w3.org/2001/XMLSchema#string

Roberto Ceravolo

http://www.w3.org/2001/XMLSchema#string

Rossella Di Stefano

http://www.w3.org/2001/XMLSchema#string

Sebastiano Quartuccio

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes

Arterial stiffness and cardiovascular events: the Framingham Heart Study

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial.

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.

P2888

s11010-017-2957-5

P304

91-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-017-2957-5

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

430

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Mandraffino

Egidio Imbalzano

Caterina Oriana Aragona

Angela D'Ascola

P577

2017-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28190172

http://www.w3.org/2001/XMLSchema#string